Basal cytokines profile in metastatic renal cell carcinoma patients treated with subcutaneous IL-2-based therapy compared with that of healthy donors
2007

Cytokine Levels in Metastatic Renal Cell Carcinoma Patients

Sample size: 199 publication 10 minutes Evidence: moderate

Author Information

Author(s): Guida Michele, Casamassima Addolorata, Monticelli Giulia, Quaranta Michele, Colucci Giuseppe

Primary Institution: National Oncology Institute, Bari, Italy

Hypothesis

Determining the levels of cytokines in metastatic renal cell carcinoma (MRCC) could help in understanding tumor growth and evaluating correlations with clinical behaviors.

Conclusion

Higher levels of certain cytokines are associated with poorer survival in metastatic renal cell carcinoma patients.

Supporting Evidence

  • Higher levels of CRP were correlated with a poorer survival.
  • Higher levels of IL-6 were associated with worse survival.
  • Higher levels of IL-8 correlated with poorer survival.
  • Higher levels of IL-12 were associated with better survival.
  • CRP and IL-12 maintained independent impact on survival in multivariate analysis.

Takeaway

This study looked at the levels of certain proteins in the blood of cancer patients and found that higher levels of some proteins mean the patients might not live as long.

Methodology

The study analyzed cytokine levels in 55 MRCC patients and 144 healthy donors, comparing their levels and correlating them with clinical outcomes.

Potential Biases

Potential biases due to the small sample size and the specific patient population studied.

Limitations

The study had a small sample size and results may not be generalizable.

Participant Demographics

55 patients with metastatic renal cell carcinoma, median age 62, 64% men.

Statistical Information

P-Value

p < 0.001 for CRP correlation with response, p = 0.0295 for IL-6 correlation with survival.

Confidence Interval

95% CI for response rate calculated.

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1479-5876-5-51

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication